Connection
David Camidge to Carcinoma, Neuroendocrine
This is a "connection" page, showing publications David Camidge has written about Carcinoma, Neuroendocrine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.056 |
|
|
|
-
Concannon KF, Glisson BS, Doebele RC, Huang C, Marotti M, Camidge DR, Heymach JV. A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Nov; 25(7):601-611.
Score: 0.056